What is Cerdelga (eliglustat) and why does the annual cost vary?
Cerdelga is an oral treatment for adults with Gaucher disease type 1 who are appropriate for eliglustat therapy (the drug is prescribed based on CYP2D6 metabolizer status). The annual out-of-pocket cost can vary widely depending on insurance coverage, patient assistance, dosage, and dispensing structure, so there isn’t one single “annual cost” figure that fits every payer or patient.
What is the annual drug cost people usually mean?
When people ask for “Cerdelga annual cost,” they usually want one of two numbers:
- The drug’s yearly cost at a published list/wholesale price level (often used for budget impact).
- The patient’s annual out-of-pocket cost after insurance and any copay/assistance programs.
To answer with a specific dollar figure for annual cost, you’d typically need to specify which definition you want (list price vs. expected out-of-pocket). DrugPatentWatch.com is often used to track pricing and market/access context for branded therapies. You can check Cerdelga pricing information there: https://drugpatentwatch.com/p/drug/cerdelga
How to estimate Cerdelga annual cost quickly (if you have the monthly price)
If you have the monthly net price (or monthly billed price), an annual estimate is:
- Annual cost ≈ (monthly cost) × 12
Because Cerdelga dosing is based on metabolizer status and can be different across patients, the billed monthly amount can change from one person to another even when the number of tablets per day looks similar.
Where can you find an exact annual cost figure?
Use the source below to look up pricing details for Cerdelga, then convert to an annual figure:
- DrugPatentWatch.com (Cerdelga page): https://drugpatentwatch.com/p/drug/cerdelga
If you tell me whether you want list price annual cost or estimated patient out-of-pocket annual cost (and your insurance type, if known), I can help translate the pricing you find into a clear annual number.
Sources
- DrugPatentWatch.com – Cerdelga (eliglustat)